chrisvoncsefalvay/vaers-outcomes huggingface dataset:
11/29/2021 Within 2 hours of receiving the shot - muscle aches, headache, joint pain, injection site sore,  11/30/2021 Headache, muscle aches, joint pain, injection site sore, shortness of breath, numbness of limbs and lower body 12/02/2021 Urinary incontinence, numbness from waist down, loss of feeling of need to urinate or have bowel movement, headache, muscle aches, joint pain, injection site sore, shortness of breath - went to Urgent Care to be seen. Due to numbness and urinary incontinence following the vaccine, this was seen as an adverse reaction to the Moderna vaccine and a referral to the ER was made immediately. She made arrangement to go to the ER for further review and testing. At ER, urine sample, blood work, CT scan. Bloodwork showed elevated inflammatory markers, blood work & urine show no infection, CT scan showed slipped disc in L4, L5, & S1(not related to vaccine reaction). Was referred to neurologist for further evaluation.  12/08/2021 Continued numbness from ribs down, urinary incontinence, numbness in limbs, headache. all adverse events have not cleared to date. cannot return to work at this time.
Admit for COVID with respiratory failure. Fully vaccinated. Given O2, steroids, remdesivir, lovenox, vit-c, zinc. Developed stroke-like symtpoms during stay and was given tKN. Able to wean to 1L NC and was discharged on HHC.
This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 05-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 05-Feb-2022) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination. No Medical History information was reported. On 05-Feb-2022 at 11:01 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 05-Feb-2022 at 11:01 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 05-Feb-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 05-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 05-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 05-Feb-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication of the patient was not reported. Ethnicity was reported as white. Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021, this vaccine was administered up until its manufacturing expiry date of 4 April 2022. No treatment information was provided by the reporter. This case was linked to MOD-2022-542869 (Patient Link).
I had the shot on Tuesday and had a  headache early friday morning, when I woke up my wife noticed that my left side of my face looked like it was sagging. By saturday  i was unable to close my eye and my  speech  began to slur.I began to have a headache and my condition remanined the same through Sunday. I went to urgent care on Monday 9/15/2021. I was diagnosed with Bells Palsy and perscribed Predinson and Valacyclovir Iwnet to my primary Doctor o 9/16/21.When the medication ran out I contined to have headaches and it was difficult to sleep at night do to the pain. On 9/31/21 got a refill fo the predinson (7 tablet). The headaches continued. I saw my doctor again ON 4/06/21. Perscriptions (x2) refill
bad headache; made her really tired; arm got sore; This is a spontaneous report from a contactable consumer (patient). This 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) (Batch/Lot Number: EN6201; Expiration Date: 30Jun2021), dose 1, via an unspecified route of administration on 02Mar2021 (at the age of 54-years-old) as a single dose for covid-19 immunisation. Medical history included borderline high blood pressure from an unknown date and unknown if ongoing, heart flutter from an unknown date and unknown if ongoing and covid-19 from an unspecified date in Nov2020. Concomitant medication(s) included verapamil (VERAPAMIL) taken for an unspecified indication, start and stop date were not reported; losartan (LOSARTAN) taken for an unspecified indication from 2020. On 02Mar2021, the patient experienced a bad headache, it made her really tired and then her arm got sore. When she arrived home after receiving the vaccination, she took Tylenol and had to lay down. Therapeutic measures included Tylenol. Clinical outcome of the events bad headache, made her really tired and her arm got sore was resolving.   No follow up attempts are needed. No further information is expected.
whenever patient felt good and did few things but experience a relapse pretty quickly; fever was close to 103; This is a spontaneous report received from a contactable consumer (patient). A 71-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9267) via unspecified route of administration in right arm on 18Feb2021 at 11:00, (at the age of 71-year-old) as a single dose for COVID-19 immunization. The patient medical history included heart and diabetes mellitus II. The patient had no known allergies. The patient was taking medication (unspecified) within two weeks of vaccination. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19 (nasal swab) on 27Feb2021 and resulted in negative. About 4 days after vaccination that was on 22Feb2021, started having mild symptoms. On 25Feb2021, the patient had fever was close to 103. Since that time patient temperature has bounced all over the place and was 102.5 this morning (on an unknown date in 2021). It was reported that whenever patient felt good and did few things but experience a relapse pretty quickly. The patient was scheduled for the second shot on 11Mar2021, and the patient was not sure what to do. The patient did not receive any treatment for the events. The outcome of the events was not recovered.
History of Present Illness:  This is a 85y.o. male with a past medical history of gout, depression, hypothyroidism, diabetes who presents to the emergency department on 1/21/2022 for strokelike symptoms with left-sided weakness.  Per EMS the patient has been having some left-sided weakness and last known well was about 1:30 in the afternoon on 1/20/2022.   These falls were unwitnessed he is unsure if he hit his head. Patient is noted to be AOx2 upon arrival but at time of my exam patient is AOx3.  According to the patient he remembers one fall. He was reaching down to grab a stool and he fell forward on to his side. He has new shoes and thinks that the soles slipped on the carpet. He denies hitting his head or losing consciousness. He denies feeling dizzy or lightheaded prior to this event. He denies feeling dizzy when changing from a seated to standing position and when he turns in bed. He denies any sided weakness or any changes in his mentation prior to coming into the hospital. He would like to leave AMA and quarantine at home with COVID. He denies any shortness of breath, cough, fever.  It was explained that he may have had a stroke and he is agreeable to stay in the hospital for further work up. He states he lives at his own apartment.      ED COURSE:  BP 168/73, HR 114, RR 18, SPO2 95%, temp 37.2.  CHEM profile remarkable for creatinine 1.25, GFR 52, glucose 196, phosphorus 2.0.  CBC remarkable for platelets 148.  UA with 2+ blood bacteria negative.  Positive for COVID.  Troponins negative.
This is a spontaneous report from a contactable health professional (other HCP) who reported that an 11-year-old child received a third dose of PREVNAR on an unspecified date for an unspecified indication. The patient had previously received a first and second dose of PREVNAR also on an unspecified dates. Titers were 50% of what they should be for streptococcus pneumoniae. The physician was considering administering the patient a single dose of PREVNAR 13.
no other AE; a dose of PROQUAD was administered after experiencing a temperature excursion.; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were not provided.   On 06-APR-2021, a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin (rHA) (PROQUAD) (lot # t005404 was evaluated and changed to T005404 based interval rules, expiration date was reported as 24-MAR-2022, but upon internal validation established as 12-AUG-2021; strength and route were unknown) was administered for prophylaxis after experiencing a temperature excursion at 37.2 degrees Fahrenheit for 3 hours (product storage error). There was no previous temperature excursion. The call was due to digital data logger. No other AE occurred. No PQC.
3/10 I woke up and there was a little red circle under where the shot went in. On subsequent days it got bigger and bigger. It was up to 5x3 inches on my arm. shoulder to elbow. It was red, raised, swollen, a little itchy, warm to the touch. on 03/12 I took a natural antihistamine.
Bump under her right breast; This spontaneous case was reported by a physician and describes the occurrence of MASS (Bump under her right breast) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced MASS (Bump under her right breast). At the time of the report, MASS (Bump under her right breast) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken in response to mRNA-1273 was not applicable. Concomitant product use was not provided. No treatment was reported.
I was not pregnant at the time of my first vaccine- I first tested positive on April 24, about 2.5 weeks after my first vaccine. This is my first pregnancy. Estimated date of delivery is December 31, 2021.   On May 3, I began spotting. I had an ultrasound where pregnancy was confirmed. On May 6 I began bleeding- I had another ultrasound that confirmed a subchorionic hematoma (SCH). Due to the level of bleeding and size of the SCH, as well as low progesterone and somewhat slow rising HCG levels (though not dangerously low), I was told to prepare for miscarriage. At a follow up appointment on May 13, one day after my second Pfizer vaccine, the ultrasound showed normal embryonic development and a heartbeat! Follow up appointment on May 20 showed continued normal development, as well as a collapsed and smaller SCH. I continue to have some light cramping and spotting.  I do not have any reason to suspect that this even was a result of the vaccine- but as it (and my positive pregnancy test) took place during the vaccination process, I wanted to report.
Vaccine administered 10/27/11, the next day patient started w/ general body aches and hives. Hives were over about 40% of body. Took BENADRYL w/ relief of symptoms over a couple of days.
This spontaneous report as received from a certified medical assistant (CMA) and a nurse refers to a 4 years old patient of unknown age (gender unknown). On 28-MAY-2014, the patient was vaccinated with (Oka/Merck) VARIVAX lot # J009990; expiration date 13-AUG-2015 (also reported as 12-AUG-2015), which was improperly exposed to 10F for 3 days and to 5-9.6F for 360 hours (also reported as exposed to 16F for 120 hours), subcutaneously. No know adverse effects. This is one of the several reports from the same source. Additional information has been requested.
Pt recv vax on 11/12/98; on 11/16/98 pt exp fever (103), achy, chills, dry cough
Patient was reported to have received a first shot of Moderna Covid-19 vaccine, and I had administered a second dose of Pfizer Covid-19 vaccine. At this time, i am not aware of any adverse reaction
Headache, shivering, fever of 100.4, nausea and vomiting (perhaps related to the fever), fatigue, significant pain at injection site.
Patient stated at night she felt an aching "like a hammer hitting" on her arm, soreness, and stiffness in the injected arm.
tired muscles, chills, couldn't sleep all night, headache, 134/78 blood pressure with 91 pulse, flu-like symptoms
Information has been received from Licensed Practical Nurse (LPN) referring to a pregnant female patient of unknown age. On 16-OCT-2012, the patient was vaccinated with her first dose of GARDASIL (lot# H010915, expiration date 13-FEB-2015, intramuscular). The second (lot# J007354, expiration date 20-FEB-2016) and third (lot# J010668, expiration date 29-APR-2016) doses were administered on 11-NOV-2013 (inappropriate schedule of drug administration) and 26-AUG-2014 (inappropriate schedule of drug administration) respectively. On 06-APR-2016 (also reported as 06-APR-2017), the patient was vaccinated with a "fourth" dose of GARDASIL 9 (lot # L019297, expiration date 18-AUG-2017, intramuscular, dose was not reported). The nurse reported that the patient was pregnant when the GARDASIL 9 was administered on 06-APR-2016 (unspecified gestation) (exposure during pregnancy). The pregnancy outcome was pending. This is one of two reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Pertinent medical history, drug allergies or reactions were not reported. On 22-SEP-2014, the patient was vaccinated with (Oka/Merck) PROQUAD lot # K008185, expiry date: 05-DEC-2015 (does and route were not reported) that underwent temperature excursion. Concomitant medication was not reported. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Left hip started hurting after 2nd dose and it worsened after the 3rd dose. The pain was mild and not enough to stop from daily tasks but noticeable esp. at night when lie down; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Apr2021 (Lot number: ER8731) as dose 2, single and administered in arm left, administration date 14Oct2021 (Lot number: FF2590) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "high blood pressure" (unspecified if ongoing). Concomitant medication(s) included: HYDROCHLOROTHIAZIDE. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER2613, Location of injection: Arm Left), administration date: 16Mar2021, when the patient was 61 years old, for Covid-19 Immunization.  The following information was reported: ARTHRALGIA (non-serious) with onset Jun2021, outcome "unknown", described as "Left hip started hurting after 2nd dose and it worsened after the 3rd dose. The pain was mild and not enough to stop from daily tasks but noticeable esp. at night when lie down". Therapeutic measures were not taken as a result of arthralgia.  Additional information: Facility where the most recent COVID-19 vaccine was administered: Other. Patient had no known allergies and had not received other vaccines in four weeks. Prior to vaccination patient was not diagnosed with COVID-19 and since the vaccination, patient has not been tested for COVID-19. Event was assessed as non-serious and not resulted in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating and Congenital anomaly/birth defect. Patient do stretches and yoga and it seemed to help a little after 2nd dose. It worsened after 3rd dose and the stretching did not alleviate. Patient don't know if it was vaccine related, was in general good health and this hip pain seemed to show up suddenly. patient regularly exercise and do yoga and pilates.  Follow-up attempts are completed. No further information is expected.
This spontaneous report was received from a register nurse, refers to an unspecified number of patients, of unknown age and gender. The patient's medical history and concurrent conditions were not reported. The register nurse information that on an unknown date, the patients were vaccinated with improperly stored doses of ROTATEQ orally, lot # K022995, expiration date: 22-JUL-2016; lot # K011947, expiration date: 07-JUN-2016. (Strength and dosage were not reported). Concomitant therapy was not reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 50-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Jan2021 as dose 1, single (Lot number: EL3249) at the age of 48 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "TBI" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "obese" (unspecified if ongoing); "known allergies: Penecillians" (unspecified if ongoing). Concomitant medication(s) included: ADDERALL, start date: 30Jul2015; GABAPENTIN, start date: 10Jun2015; OMEPRAZOLE, start date: 01Aug2007. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: Blood cholesterol: high. Therapeutic measures were taken as a result of drug ineffective, suspected covid-19.
Doctor prescribe PERCOCET - for flu - had chills/weakness/burning sensation. Went to hospital on 10/3/17 diagnosed w/pneumonia. Flu lated about 2-3 weeks. Christmas Even patient has dots underskin, noted breast area, itchy, burning, stabbing pain. On 12/20/17 Patient hospital - diagnosed w/shingles.
Dizziness, Headache, Phlebitis & ErythemaMultiform  Narrative:
Syncope (likely vasovagal), recovered in <5 min to baseline. Was given Gatorade and crackers and vital signs were monitored.
had some itchiness on her neck; This is a spontaneous report from a contactable consumer (patient) via Pfizer sponsored program. A female patient of an unspecified age received BNT162B2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 12Mar2021 as Dose 1, Single and via an unspecified route of administration on 02Apr2021 as Dose 2, Single for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that she had experienced some itchiness on her neck after the 1st dose (12Mar2021) and continuously happening until now. She had her second dose (last 2nd of April). The outcome of the event itchiness on her neck was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Dizziness, Hallucinations, swollen arm/arm pit; headache; dizziness Narrative:  Tylenol as needed  Other Relevant History:
sensation of internal itching; prickling sensation over the skin; focused and prevalent to the pubic area; This spontaneous case was reported by a nurse and describes the occurrence of PRURITUS (sensation of internal itching), PARAESTHESIA (prickling sensation over the skin) and VULVOVAGINAL DISCOMFORT (focused and prevalent to the pubic area) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     Concomitant products included DULOXETINE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PRURITUS (sensation of internal itching), PARAESTHESIA (prickling sensation over the skin) and VULVOVAGINAL DISCOMFORT (focused and prevalent to the pubic area). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) at an unspecified dose and frequency. At the time of the report, PRURITUS (sensation of internal itching), PARAESTHESIA (prickling sensation over the skin) and VULVOVAGINAL DISCOMFORT (focused and prevalent to the pubic area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
SEVERE ITCHING, HIVES, SWELLING, REDNESS, SHE WENT TO THE DOCTOR WHO DREW A CIRCLE AROUND THE REACTION AREA TO MONITOR SPREAD, PRESCRIPTION MEDICATION WAS GIVEN FOR REACTION
17 year old female ,  - received vaccination at event. Her parents approved of vaccination - she did not disclose age prior to vaccination . Would like to proceed with 2nd vaccination - parents approve . Minor consent to be signed Minimal arm soreness post injection
She received her vaccine on the 1/4/2021.  She had localized discomfort for a few days.  On 1/12/21 she noticed a lump and redness on her upper arm.  The lump and redness has increased in size.  She returned today and it has doubled in size (redness 170cm x 145cm and lump 135cm x 130 cm).
Information has been received from a physician concerning an over 11 year old female who was vaccinated intramuscularly with a dose of HPV rL1 6 11 16 18 VLP vaccine (yeast). Subsequently the patient experienced dizziness. The patient did not seek medical attention. Subsequently, the patient recovered. Additional informtion has been requested.
This spontaneous report was received from a nurse practitioner referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 08-SEP-2016, the patient was vaccinated with improperly stored dose of VAQTA lot number reported as: LN749, expiry date: 26-AUG-2018 (strength, dose number, route and anatomical location were not provided). Concomitant therapies were not provided. This is one of the several reports received from the same reporter. Additional information has been requested.
Six hours, post vax, the pt experienced swelling (nos) and joint pain. No treatment was given. Symptoms resolved 3-4 months later. The most recent information, received on 12/15/1999, reported the condition of the pt is resolved.